Revance Therapeutics, Inc. Gains 54.34%

Mon, Jan 09, 2023 at 07:02 PM
Revance Therapeutics, Inc. Gains 54.34%

Revance Therapeutics, Inc. (RVNC:NASDAQ) jumped higher at $30.42, representing a gain of 54.3%. On Mon, Jan 09, 2023, RVNC:NASDAQ touched a New 2-Week High of $30.42. The stock appeared on our News Catalysts scanner on Mon, Jan 09, 2023 at 09:29 AM in the 'INVESTOR UPDATE' category. From Tue, Dec 27, 2022, the stock recorded 50.00% Up Days and 66.67% Green Days

The stock spiked on Fri, Oct 07, 2022 at $30.95 with a volume of 1M+.

About Revance Therapeutics, Inc. (RVNC:NASDAQ)

Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.